Dr. Michael Zelefsky, MD
Claim this profileMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Studies Prostate Cancer
Studies Squamous Cell Carcinoma
5 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Michael Zelefsky, MD is currently running
SBRT
for Prostate Cancer
The researchers are doing this study to find out if stereotactic body radiation therapy (SBRT) without androgen deprivation therapy (ADT) is an effective treatment approach for people with unfavorable intermediate-risk prostate. The researchers will see whether SBRT can prevent participants' cancer from coming back and/or spreading to other parts of the body. In addition, they will look closely at how safe and effective it is to rely on Decipher test results for determining which patients would benefit from more extensive radiation treatments
Recruiting1 award Phase 2
177Lu-PSMA-617 + SBRT
for Prostate Cancer
The researchers are doing this study to find out whether giving 177Lu-PSMA-617 followed by a type of radiation therapy called SBRT (stereotactic body radiation therapy) is a safe treatment for your cancer. The study agent has been shown to target tumor cells, and the researchers think that adding 177Lu-PSMA-617 to SBRT may prevent or delay the cancer from continuing to spread.
Recruiting1 award Phase 1
More about Michael Zelefsky, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael Zelefsky, MD has experience with
- Biopsy
- Dynamic Contrast-enhanced MRI (DCE)
- Multi-parametric MRI(MP-MRI)
- 177Lu-PSMA-617
- Stereotactic Body Radiotherapy (SBRT)
- PET Scan
Breakdown of trials Michael Zelefsky, MD has run
Prostate Cancer
Squamous Cell Carcinoma
Basal cell carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Zelefsky, MD specialize in?
Michael Zelefsky, MD focuses on Prostate Cancer and Squamous Cell Carcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Michael Zelefsky, MD currently recruiting for clinical trials?
Yes, Michael Zelefsky, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Michael Zelefsky, MD has studied deeply?
Yes, Michael Zelefsky, MD has studied treatments such as biopsy, dynamic contrast-enhanced MRI (DCE), multi-parametric MRI(MP-MRI).
What is the best way to schedule an appointment with Michael Zelefsky, MD?
Apply for one of the trials that Michael Zelefsky, MD is conducting.
What is the office address of Michael Zelefsky, MD?
The office of Michael Zelefsky, MD is located at: Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.